48 results
P
patients with rheumatoid arthritis (RA)
I/C
systematic review and meta-analysis, studies with heterogeneous methods to identify RA-BR
O
prevalence of RA-BR among RA patients
P
SLE, RA, controls
I/C
periodontitis, SLE vs RA, controls
O
prevalence and odds ratio
P
patients with osteoarthritis (OA), patients with rheumatoid arthritis (RA)
I/C
Total hip arthroplasty (THA), outcomes in patients with RA versus OA
O
revision, hip dislocation, periprosthetic infection, wound infection, revision for late infection
P
patients with rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA)
I/C
coeliac disease (CD), biopsy-confirmed CD in RA and JIA patients
O
pooled prevalence estimates of biopsy-confirmed CD and positive CD serology
P
1361 rheumatoid arthritis (RA) patients, 706 RA patients
I/C
TNF inhibitors (TNFi), change in disease activity score 28 (ΔDAS28)
O
association with response to TNFi
P
RA, pre-eclampsia
I/C
genome-wide association studies, Finn biobank
O
adverse obstetric outcomes
P
RA patients, LC patients
I/C
O
LC risk
P
RA cases, normal participants
I/C
SAA levels, control group
O
DAS28, ESR, CRP, RF, IL-4, IL-6, IL-10, IL-17, A-CCP, hemoglobin
P
statin-users, non-users
I/C
statin use, statin-users vs non-users
O
risk of rheumatoid arthritis (RA)
P
patients with rheumatoid arthritis (RA)
I/C
Vitamin D supplementation, disease activity
O
low levels of serum vitamin D levels